Pepgen
PepGen is empowering nucleic acid therapeutics to go the distance.
About Pepgen
PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and they are advancing novel conjugate therapeutics to the clinic.
Company Facts
- Headquarters
- Oxford
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00051_00100
- Funding Stage
- ipo
- Total Funding
- $354,675,523
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2025-09-24
- Website
- pepgen.com
Industries & Categories
Biotechnology, Clinical Trials, Medical
Social Links
Canonical: https://fsome.com/organization/pepgen-46914 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.